Name | N-benzyl-2-chloro-9-methylpurin-6-amine |
---|---|
Synonyms |
6-benzylamino-2-chloro-9-methylpurine
2-Chloro-9-methyl-6-benzylaminopurine 2-chloro-6-benzylamino-9-methylpurine N-Benzyl-2-Chloro-9-Methyl-9H-Purin-6-Amine |
Description | CDK2-IN-13 (Compound 15) is a CDK2 inhibitor with IC50 of 12 µM. CDK2-IN-13 can be used in research of cancer[1]. |
---|---|
Related Catalog | |
Target |
IC50:12 µM (CDK2)[1]. |
Density | 1.4g/cm3 |
---|---|
Boiling Point | 443.1ºC at 760 mmHg |
Molecular Formula | C13H12ClN5 |
Molecular Weight | 273.72100 |
Flash Point | 221.8ºC |
Exact Mass | 273.07800 |
PSA | 55.63000 |
LogP | 2.70180 |
Vapour Pressure | 4.77E-08mmHg at 25°C |
Index of Refraction | 1.702 |
HS Code | 2933990090 |
---|
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |